Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 171 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1701 3.3 months Transitional cell carcinoma of the urothelial tract 5 Biologic therapy
Université catholique de Louvain Belgium 10/2012
Treatment Details: Patients: This phase 2 study involved 37 previously treated patients with transitional cell carcinoma of the urothelial tract (a form of bladder cancer). The median patient age was 63 year
 
1702 3.3 months Metastatic melanoma and brain metastasis 5 Biologic therapy
Toulouse III University and Larrey Hospital France 7/2013
Treatment Details: Patients: This study involved 38 metastatic melanoma patients with brain metastasis. The median patient age was 50 years and 68.4% were male. Treatment: Patients were treated with the
 
1703 3.2 months GBM 4 Biologic therapy
Chemotherapy
Mayo Clinic United States 11/2011
Treatment Details: Patients: This phase II study involved 37 recurrent glioblastoma (GBM) patients with a median age of 51.5 years; 73% were male. Treatment: Patients were treated with the chemotherapy dr
 
1704 3.2 months MPM 3 Chemotherapy
San Matteo University Hospital Italy 6/2005
Treatment Details: Patients: This Phase II study involved 14 patients with malignant pleural mesothelioma. Eleven patients were men, and three were women. The median age was 59.5 years. All patients receive
 
1705 3.1 months SCLC 3 Chemotherapy
University General Hospital of Alexandroupolis Greece 9/2010
Treatment Details: Patients: This study involved 31 small-cell lung cancer patients with a median age of 64 years and 90.3% were male. All patients were in early relapse after previous chemotherapy. Treat
 
1706 3.0 months Unresectable hepatocellular (liver) carcinoma 4 Chemotherapy
Immunotherapy
Sylvester Comprehensive Cancer Center, University of Miami United States 1/2003
Treatment Details: Patients: Thirty patients with unresectable hepatocellular (liver) carcinoma were entered into this Phase II trial. Treatment: Treatment consisted of a combination of the chemotherapy dr
 
1707 2.9 months Recurrent GBM 3 Biologic therapy
Chemotherapy
Duke University Medical Center United States 9/2010
Treatment Details: Patients: This study involved a total of 23 glioblastoma multiforme patients who had progressed following previous treatment with bevacizumab. Patients were separated into 2 separate treat
 
1708 2.8 months Advanced NSCLC 4 Chemotherapy
Aomori Prefectural Central Hospital Japan 5/2014
Treatment Details: Patients: This phase 2 study involved 20 advanced non-small cell lung cancer patients with a median age of 68.8 years, 16 of whom were male. Treatment: Patients received chemotherapy wi
 
1709 2.6 months GBM 3 Biologic therapy
Brigham and Women's Hospital United States 1/2015
Treatment Details: Patients: This phase 2 study involved high-grade glioma (glioblastoma or anaplastic glioma) patients who were divided into groups based on prior treatment. Group A consisted of 22 patients
 
1710 2.5 months Metastatic rcc 4 Biologic therapy
City of Hope National Medical Center United States 5/2007
Treatment Details: Patients: This phase II study involved 23 patients with advanced metastatic renal cancer. Fourteen were men and 9 were women. The median age was 60 years, ranging from 40 to 70. Trea
 
Page 171 of 187  | Previous Page  | Next Page